Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Lantheus_Holdings
|
| gptkbp:acquisitionYear |
2020
|
| gptkbp:focusArea |
oncology
therapeutics diagnostics |
| gptkbp:founded |
1986
|
| gptkbp:founder |
gptkb:Paul_J._Maddon
|
| gptkbp:headquarters_location |
gptkb:New_York,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Progenics Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Relistor
gptkb:Azedra |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
gptkb:PGNX
|
| gptkbp:website |
www.progenics.com
|
| gptkbp:bfsParent |
gptkb:William_J._Doyle
|
| gptkbp:bfsLayer |
6
|